Nick Shipley, the top lobbyist for the Biotechnology Innovation Organization (BIO), has left the organization amid reported differences in policy and priorities, as confirmed exclusively by Jared Whitlock. His departure is seen as part of a broader reorganization within BIO, which has been grappling with US-China tensions and internal disagreements over the Biosecure Act. The exit of Shipley, who was known for his opposition to the Biosecure Act before BIO's stance shifted, coincides with the tenure of BIO's new CEO, John Crowley. This move signals potential further changes under Crowley's leadership, as the biotech industry's largest trade group faces a period of organizational tumult, with the group confirming the departure to STAT. The story was also covered by Rachel Cohrs and John Wilkerson.
The biotech industry’s largest trade group has parted ways with its top lobbyist, the group confirmed to STAT, adding to a recent bout of organizational tumult. https://t.co/WIr6GbSDjk
More tumult at BIO: The group's top lobbyist exits suddenly, and its new CEO signals that more changes may be on the way https://t.co/yvuFuzaL00
BIO’s top lobbyist exits, signaling reorganization https://t.co/nFhgu6AToh via @rachelcohrs @john_wilkerson
The exit of BIO's top lobbyist might be part of a larger shakeup under the trade group's new CEO John Crowley. By @rachelcohrs and me. https://t.co/IIdBLqrgwR
Shipley was fiercely opposed to the Biosecure Act before BIO flipped... Top lobbyist at BIO leaves as trade group grapples with US-China tensions - https://t.co/XnOOmfmRSV
Nick Shipley, top lobbyist at @IAmBiotech has left the group: “It was clear that there were just some differences in policy and priorities that were emerging that led to a decision to move on in different directions." Exclusive from @Jared_Whitlock. https://t.co/eLbC3Lqv4F